A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults

NCT05089630 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

339

Enrollment

INDUSTRY

Sponsor class

Conditions

Cytomegalovirus Infections

Interventions

BIOLOGICAL: Pentamer (low)/gB(low)/Adjuvant vaccine
BIOLOGICAL: Pentamer (med)/gB(low)/Adjuvant vaccine
BIOLOGICAL: Pentamer (med)/gB(med)/Adjuvant vaccine
BIOLOGICAL: Pentamer (high)/gB(med)/Adjuvant vaccine
COMBINATION_PRODUCT: Placebo (saline)

Sponsor

GlaxoSmithKline